UNSPSC 51203100: Immunosupressant peptides

This classification denotes compounds consisting of amino acids bound by peptide bonds branched, cyclical, or linear structures, substances called peptides, that reduce a human host's humoral and/or cell-mediated defense mechanisms against deviant native cells, foreign organisms, or foreign substances (the human immune response and system thereof), thus the term IMMUNOSUPRESSANT PEPTIDES.

UNSPSC 51203100 Immunosuppressant peptides is a Class code that in practice covers emergency response and healthcare supply procurement by state and local governments, though the recent opportunities show minimal alignment with the code's nominal pharmaceutical scope. The recent solicitations under this code involve naloxone and drug deactivation systems for public health initiatives, medical and first aid supplies for fire department rescue operations, generic pharmaceuticals and OTC products through cooperative purchasing vehicles, and exploratory procurement for direct-to-manufacturer pharmacy initiatives. Issuing bodies include county health departments (Seminole County, Florida), municipal fire departments (City of Tampa), state health and human services agencies (Texas HHS Commission), and multistate cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance, or MMCAP). The code appears to serve as a catch-all taxonomy category for diverse pharmaceutical and medical supply procurements rather than a specialized immunosuppressant-focused category.

Geographic activity centers on Florida and Minnesota, with participation from Texas and Oregon through cooperative purchasing arrangements. Representative recent opportunities include Seminole County's IFB 60459723LAS (posted June 30, 2026, due July 26, 2023) for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries; the City of Tampa's IFB 26P00145 (posted March 25, 2026, due March 13, 2026) for 169 line items of medical and first aid supplies for the Fire Department Rescue Division, estimated at $700,000.00 and designated as a sheltered market opportunity for certified Small Local Business Enterprises with a 5 percent bid discount; MMCAP's RFP S1070000015802 (posted January 20, 2026, due March 26, 2026) establishing multiple contracts for generic pharmaceuticals and OTC products distributed across state and local government facilities; and the Texas HHS Commission's RFI HHS0017013 (posted April 3, 2026, due April 3, 2026) exploring direct-to-manufacturer prescription programs for state pharmacy benefit management. The code shows no standout repeat buyers across the recent sample.